Evidence map›Paper›PMID 37366052›Full record

ArticleDevelopment (Cambridge, England)2023

Pleiotropy of autism-associated chromatin regulators.

Micaela Lasser, Nawei Sun, Yuxiao Xu, Sheng Wang, Sam Drake, Karen Law, Silvano Gonzalez, Belinda Wang, Vanessa Drury, Octavio Castillo and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Development (Cambridge, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Pharmaco-behavioral profiling identifies suppressors of autism gene-associated phenotypes in zebrafish.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Novel mouse line with D277N mutation in theFrontiers in cell and developmental biology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Functional Neurogenomics to Dissect Disease Mechanisms Across Models.Annual review of genomics and human genetics · 2025
    Review
  11. Article
  12. Article
  13. Disrupted diencephalon development and neuropeptidergic pathways in zebrafish with autism-risk mutations.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Convergence of autism proteins at the cilium.bioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Review
  18. Review
  19. A roadmap to cure CHD2-related disorders.Therapeutic advances in rare disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Micaela LasserDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-4737-1197
Nawei SunDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-1599-5990
Yuxiao XuDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Sheng WangDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-1809-3116
Sam DrakeDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Karen LawDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-1274-3392
Silvano GonzalezDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Belinda WangDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0001-5563-894X
Vanessa DruryDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Octavio CastilloDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Yefim ZaltsmanDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-2979-8197
Jeanselle DeaDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0003-3831-3558
Ethel BaderDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Kate E McCluskeyDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Matthew W StateDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0003-1624-8302
A Jeremy WillseyDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-9922-3612
Helen Rankin WillseyDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0001-8404-3291
University of California, San Francisco · US

Funding

The Psychiatric Cell Map Initiative: Connecting Genomics, Subcellular Networks, and Higher Order PhenotypesU01MH115747 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KAMPMANN, MARTIN, KROGAN, NEVAN J · 2018 to 2022
$19.6M
TRAINING THE NEXT GENERATION OF MENTAL HEALTH RESEARCHERSR25MH060482 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DANIEL H MATHALON, Susan M. Voglmaier · 2000 to 2026
$5.2M
2/2 - Cell Type and Region-Specific Regulatory Networks in Human Brain Development and DisordersU01MH116487 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STATE, MATTHEW W. · 2018 to 2022
$2.3M
NIMH NIH HHS R25 MH060482NIMH NIH HHS U01 MH115747NIMH NIH HHS U01 MH116487
6 · The paper itself

Abstract

Gene ontology analyses of high-confidence autism spectrum disorder (ASD) risk genes highlight chromatin regulation and synaptic function as major contributors to pathobiology. Our recent functional work in vivo has additionally implicated tubulin biology and cellular proliferation. As many chromatin regulators, including the ASD risk genes ADNP and CHD3, are known to directly regulate both tubulins and histones, we studied the five chromatin regulators most strongly associated with ASD (ADNP, CHD8, CHD2, POGZ and KMT5B) specifically with respect to tubulin biology. We observe that all five localize to microtubules of the mitotic spindle in vitro in human cells and in vivo in Xenopus. Investigation of CHD2 provides evidence that mutations present in individuals with ASD cause a range of microtubule-related phenotypes, including disrupted localization of the protein at mitotic spindles, cell cycle stalling, DNA damage and cell death. Lastly, we observe that ASD genetic risk is significantly enriched among tubulin-associated proteins, suggesting broader relevance. Together, these results provide additional evidence that the role of tubulin biology and cellular proliferation in ASD warrants further investigation and highlight the pitfalls of relying solely on annotated gene functions in the search for pathological mechanisms.

Indexed as

Autism Spectrum DisorderAutistic DisorderChromatinHistonesHumansMicrotubulesSpindle ApparatusTubulinChromatinHistonesTubulinAutism spectrum disorderCell cycleChromatinCiliaHumanMicrotubulesSpindlesTubulinXenopus

Identifiers

PMID37366052
PMCPMC10399978
OpenAlexW4382182422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.